Wilcoxon rank-sum test comparing the PSQI scores within each component of sleep quality in patients with PsA or PsC, and HC. Range for each variable is 0–3, except for PSQI, which is 0–21.
Variable | Comparison | p | Comparison | p | Comparison | p |
---|---|---|---|---|---|---|
Duration of sleep | PsC vs PsA | 0.5351 | PsC vs HC | 0.1837 | PsA > HC | 0.0425* |
Sleep disturbance | PsC < PsA | 0.0056* | PsC > HC | 0.0005* | PsA > HC | < 0.0001* |
Sleep latency | PsC < PsA | < 0.0001* | PsC vs HC | 0.2479 | PsA > HC | 0.0028* |
Daytime dysfunction due to sleepiness | PsC < PsA | 0.0091* | PsC vs HC | 0.2035 | PsA > HC | < 0.0001* |
Sleep efficiency** | PsC vs PsA | 0.4434 | PsC > HC | 0.0029* | PsA > HC | < 0.0001* |
Need for sleep medications | PsC vs PsA | 0.2072 | PsC vs HC | 0.4646 | PsA > HC | 0.0474* |
Patient-perceived sleep quality | PsC < PsA | 0.0034* | PsC vs HC | 0.8905 | PsA > HC | 0.0011* |
PSQI score | PsC < PsA | < 0.0001* | PsC > HC | 0.0069* | PsA > HC | < 0.0001* |
↵* Statistical significance was defined as p < 0.05.
↵** Sleep efficiency was calculated by the following formula and appropriately scored: (total no. hours asleep)/(total no. hours in bed) × 100. PSQI: Pittsburgh Sleep Quality Index; PsA: psoriatic arthritis; PsC: psoriasis without arthritis; HC: healthy controls.